Hot Features
EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Li... EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erectile dysfunction. It also offers Lactobacillus rhamnosus Beebiotic MAP01, a proprietary strain to support digestive health and vitality. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0005 | 2.12765957447 | 0.0235 | 0.026 | 0.022 | 117189 | 0.02491024 | DE |
| 4 | -0.005 | -17.2413793103 | 0.029 | 0.029 | 0.022 | 229805 | 0.02595387 | DE |
| 12 | 0.001 | 4.34782608696 | 0.023 | 0.032 | 0.017 | 952231 | 0.02630014 | DE |
| 26 | -0.003 | -11.1111111111 | 0.027 | 0.032 | 0.017 | 610442 | 0.02502533 | DE |
| 52 | -0.01 | -29.4117647059 | 0.034 | 0.038 | 0.017 | 573027 | 0.02746792 | DE |
| 156 | 0.023 | 2300 | 0.001 | 0.038 | 0.001 | 1013423 | 0.00973628 | DE |
| 260 | 0.019 | 380 | 0.005 | 0.038 | 0.001 | 3341475 | 0.00369271 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.